Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,732.70
-13.88
(-0.12%)
NZD/USD
0.6028
-0.0006
(-0.10%)
NZD/EUR
0.5591
-0.0003
(-0.05%)
ALL ORDS
8,035.60
+41.40
(+0.52%)
ASX 200
7,763.00
+41.40
(+0.54%)
OIL
79.85
+0.59
(+0.74%)
Kiniksa Pharmaceuticals, Ltd. (KNSA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.19
-0.07
(-0.35%)
At close: 04:00PM EDT
20.88
+0.69
(+3.42%)
After hours:
06:38PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
301,772
270,259
220,180
38,544
0
Cost of revenue
49,467
33,407
22,895
9,100
0
Gross profit
252,305
236,852
197,285
29,444
0
Operating expenses
Research development
87,259
76,097
65,490
99,297
112,042
Selling general and administrative
139,064
129,427
97,951
85,948
45,321
Total operating expenses
282,847
262,048
187,512
186,080
157,363
Operating income or loss
-30,542
-25,196
9,773
-156,636
-157,363
Total other income/expenses net
8,978
8,544
1,253
97
-
Income before tax
-21,564
-16,652
11,026
-156,539
-156,229
Income tax expense
-30,214
-30,736
-172,337
1,385
5,152
Income from continuing operations
8,650
14,084
183,363
-157,924
-161,381
Net income
8,650
14,084
183,363
-157,924
-161,381
Net income available to common shareholders
8,650
14,084
183,363
-157,924
-161,381
Basic EPS
-0.10
-
2.64
-2.30
-2.61
Diluted EPS
-0.11
-
2.60
-2.30
-2.61
Basic average shares
69,868
-
69,382
68,577
61,843
Diluted average shares
70,172
-
70,421
68,577
61,843
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.